References
Key articles
Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. BMJ. 2021 Jul 12;374:n1380.Full text Abstract
Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013 Aug 15;9(1):30.Full text Abstract
Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab. 2024 Jun 17;109(7):1657-83.Full text Abstract
Arlt W; Society for Endocrinology Clinical Committee. Society for Endocrinology endocrine emergency guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocr Connect. 2016 Sep;5(5):G1-3.Full text Abstract
Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020 May;75(5):654-63.Full text Abstract
Reference articles
1. Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. BMJ. 2021 Jul 12;374:n1380.Full text Abstract
2. Goldbloom EB, Mokashi A, Cummings EA, et al. Symptomatic adrenal suppression among children in Canada. Arch Dis Child. 2017 Apr;102(4):338-9. Abstract
3. Broersen LH, Pereira AM, Jørgensen JO, et al. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015 Jun;100(6):2171-80.Full text Abstract
4. Rensen N, Gemke RJ, van Dalen EC, et al. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. Cochrane Database Syst Rev. 2017 Nov 6;(11):CD008727.Full text Abstract
5. Joseph RM, Hunter AL, Ray DW, et al. Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review. Semin Arthritis Rheum. 2016 Aug;46(1):133-41.Full text Abstract
6. Smith RW, Downey K, Gordon M, et al. Prevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid. Paediatr Child Health. 2012 May;17(5):e34-9.Full text Abstract
7. Sidoroff M, Kolho KL. Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy. BMC Gastroenterol. 2014 Mar 24;14:51.Full text Abstract
8. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013 Aug 15;9(1):30.Full text Abstract
9. Bowden SA, Connolly AM, Kinnett K, et al. Management of adrenal insufficiency risk after long-term systemic glucocorticoid therapy in duchenne muscular dystrophy: clinical practice recommendations. J Neuromuscul Dis. 2019;6(1):31-41.Full text Abstract
10. Johnston PC, Lansang MC, Chatterjee S, et al. Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function. Endocrine. 2015 Mar;48(2):410-6. Abstract
11. Iranmanesh A, Gullapalli D, Singh R, et al. Hypothalamo-pituitary-adrenal axis after a single epidural triamcinolone injection. Endocrine. 2017 Aug;57(2):308-13. Abstract
12. Ahmet A, Kim H, Spier S. Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy Asthma Clin Immunol. 2011 Aug 25;7(1):13.Full text Abstract
13. Wlodarczyk JH, Gibson PG, Caeser M. Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review. Ann Allergy Asthma Immunol. 2008 Jan;100(1):23-30. Abstract
14. Scutelnicu A, Panaitescu AM, Ciobanu AM, et al. Iatrogenic Cushing's syndrome as a consequence of nasal use of betamethasone spray during pregnancy. Acta Endocrinol (Buchar). 2020 Oct-Dec;16(4):511-7. Abstract
15. Güven A. Different potent glucocorticoids, different routes of exposure but the same result: iatrogenic Cushing’s syndrome and adrenal insufficiency. J Clin Res Pediatr Endocrinol. 2020 Nov 25;12(4):383-92.Full text Abstract
16. Nieman LK. Consequences of systemic absorption of topical glucocorticoids. J Am Acad Dermatol. 2011 Jul;65(1):250-2. Abstract
17. Delitala AP, Fanciulli G, Maioli M, et al. Primary symptomatic adrenal insufficiency induced by megestrol acetate. Neth J Med. 2013 Jan;71(1):17-21. Abstract
18. Malik KJ, Wakelin K, Dean S, et al. Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate. Ann Clin Biochem. 1996 May;33 (Pt 3):187-9. Abstract
19. Chan CM, Mitchell AL, Shorr AF. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med. 2012 Nov;40(11):2945-53. Abstract
20. Bertagna C, Orth DN. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med. 1981 Nov;71(5):855-75. Abstract
21. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med. 1990 Apr 26;322(17):1195-201.Full text Abstract
22. Hawcutt DB, Francis B, Carr DF, et al. Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study. Lancet Respir Med. 2018 Jun;6(6):442-50.Full text Abstract
23. Mebrahtu TF, Morgan AW, Keeley A, et al. Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England. J Clin Endocrinol Metab. 2019 Apr 22;104(9):3757-67.Full text Abstract
24. Schuetz P, Christ-Crain M, Schild U, et al. Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med. 2008 Jan 26;8:1.Full text Abstract
25. Streck WF, Lockwood DH. Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med. 1979 Jun;66(6):910-4. Abstract
26. Villabona CV, Koh C, Panergo J, et al. Adrenocorticotropic hormone stimulation test during high-dose glucocorticoid therapy. Endocr Pract. 2009 Mar;15(2):122-7. Abstract
27. Duclos M, Guinot M, Colsy M, et al. High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med Sci Sports Exerc. 2007 Jul;39(7):1036-43. Abstract
28. Mader R, Lavi I, Luboshitzky R. Evaluation of the pituitary-adrenal axis function following single intraarticular injection of methylprednisolone. Arthritis Rheum. 2005 Mar;52(3):924-8.Full text Abstract
29. Lansang MC, Farmer T, Kennedy L. Diagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injections. Endocr Pract. 2009 Apr;15(3):225-8. Abstract
30. Brennan V, Martin-Grace J, Greene G, et al. The contribution of oral and inhaled glucocorticoids to adrenal insufficiency in asthma. J Allergy Clin Immunol Pract. 2022 Oct;10(10):2614-23. Abstract
31. Wilson KS, Gray CE, Cameron EH, et al. Hypothalamic/pituitary/adrenal function in patients treated with intermittent high-dose prednisolone and cytotoxic chemotherapy. Lancet. 1976 Mar 20;1(7960):610-2.Full text Abstract
32. Einarsdottir MJ, Kristjansdottir HL, Bergthorsdottir R, et al. Intermittent high-dose glucocorticoid treatment does not cause adrenal insufficiency in patients with diffuse large B-cell lymphoma: a Pprospective study. Acta Haematol. 2024;147(3):360-5.Full text Abstract
33. Lee H, Yoon HY. Inhaled corticosteroid increased the risk of adrenal insufficiency in patients with chronic airway diseases: a nationwide population-based study. Sci Rep. 2024 Nov 21;14(1):28831.Full text Abstract
34. Ahmet A, Rowan-Legg A, Pancer L. Adrenal suppression from exogenous glucocorticoids: recognizing risk factors and preventing morbidity. [in fre]. Paediatr Child Health. 2021 Jul;26(4):242-54.Full text Abstract
35. Schurmeyer TH, Tsokos GC, Avgerinos PC, et al. Pituitary-adrenal responsiveness to corticotropin-releasing hormone in patients receiving chronic, alternate day glucocorticoid therapy. J Clin Endocrinol Metab. 1985 Jul;61(1):22-7. Abstract
36. Nakamura M, Abrouk M, Zhu H, et al. Update on the systemic risks of superpotent topical steroids. J Drugs Dermatol. 2017 Jul 1;16(7):643-8. Abstract
37. Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab. 2024 Jun 17;109(7):1657-83.Full text Abstract
38. Arlt W; Society for Endocrinology Clinical Committee. Society for Endocrinology endocrine emergency guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocr Connect. 2016 Sep;5(5):G1-3.Full text Abstract
39. Henzen C, Suter A, Lerch E, et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet. 2000 Feb 12;355(9203):542-5. Abstract
40. National Institute for Health and Care Excellence. Adrenal insufficiency: identification and management. Aug 2024 [internet publication].Full text
41. Mehlich A, Bolanowski M, Mehlich D, et al. Medical treatment of Cushing's disease with concurrent diabetes mellitus. Front Endocrinol (Lausanne). 2023;14:1174119.Full text Abstract
42. El-Farhan N, Rees DA, Evans C. Measuring cortisol in serum, urine and saliva - are our assays good enough? Ann Clin Biochem. 2017 May;54(3):308-22.Full text Abstract
43. Thevenot T, Borot S, Remy-Martin A, et al. Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisol. Liver Int. 2011 Mar;31(3):425-33. Abstract
44. Galbois A, Rudler M, Massard J, et al. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J Hepatol. 2010 Jun;52(6):839-45. Abstract
45. Grinspoon SK, Biller BM. Clinical review 62: laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994 Oct;79(4):923-31. Abstract
46. Debono M, Elder CJ, Lewis J, et al. Home waking salivary cortisone to screen for adrenal insufficiency. NEJM Evid. 2023 Feb;2(2):EVIDoa2200182.Full text Abstract
47. Debono M, Caunt S, Elder C, et al. Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency. Clin Endocrinol (Oxf). 2023 Dec;99(6):517-24.Full text Abstract
48. Pelewicz K, Miśkiewicz P. Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice. Diagnostics (Basel). 2021 Apr 20;11(4):728.Full text Abstract
49. Liu MM, Reidy AB, Saatee S, et al. Perioperative steroid management: approaches based on current evidence. Anesthesiology. 2017 Jul;127(1):166-72.Full text Abstract
50. Arafah BM. Perioperative glucocorticoid therapy for patients with adrenal insufficiency: dosing based on pharmacokinetic data. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgaa042. Abstract
51. Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020 May;75(5):654-63.Full text Abstract
52. Hopkins RL, Leinung MC. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am. 2005 Jun;34(2):371-84;ix. Abstract
53. Stewart PM. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, et al., eds. Williams textbook of endocrinology. 10th ed. Philadelphia, PA: WB Saunders; 2003:491-551.
Use of this content is subject to our disclaimer